While investors might have missed Carvana's 4,300% surge over the past three years, here's why it can keep soaring higher.

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the stocks mentioned during the show, as we cover everything Jim Cramer said about the oversold market. When a caller inquired about the stock during the ...

The data engineer started as a casual reader of the Jeffrey Epstein files. Then he became obsessed, and built the most ...

Stop guessing why your PC lagged. This Task Manager alternative logs three days of performance history to catch spikes that ...

The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird Bioscience. Piers Ingram, the cofounder and CEO of the company, was nervous, but ...

This week’s Top 10 explores fraud and ID verification platforms such as Entrust and Socure that are redefining digital trust ...

New capability gives security teams visibility and control over AI agents operating across their SaaS environment.

Unlike Nvidia's earlier Grace processors, which were primarily sold as companions to GPUs, Vera is positioned as a ...

by Eleanor Warnock Whether or not you believe that flawed Anthropic graph or Jack Dorsey’s stated reasons for laying off 40 percent of his staff at Block, the message is the same: AI is doing more of ...

February showed AI accelerating through defense conflict, layoffs, autonomous agents, and search automation reshaping society.

With the MAHA movement poised to introduce a lot more "integrative" or "complementary and alternative" treatments into oncology (and medicine in general), a new study shows the likely result.

Abnormal AI , the leader in AI-native behavioral security, today announced the launch of Attune 1.0, a behavioral foundation model for cy ...